1AI 0.00% 1.0¢ algorae pharmaceuticals limited

Ann: Approval granted for group 3 in Parkinsons trial, page-17

  1. 2,976 Posts.
    lightbulb Created with Sketch. 69
    ..if you, personally, were to get involved in social media and contacted all the Parkinson's groups, your effort would probably exceed the companies effort as you are independent

    i spoke on this in the past and got the bollox for it, but, truth is , groups listen, of course they listen, the groups the most directly affected are always listening but they only listen for tangible results, first proof and peer-reviewed evidence .......so there's the challenge..in this instance peer review is essentially the patient

    the company is in a bind, they can hype promote and win when the product proves itself or they can utterly destroy itself by hyping a product that maybe, well, less than workable...so baby steps required

    stock holders are not bound
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $16.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $1.3K 130K

Buyers (Bids)

No. Vol. Price($)
7 4791986 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1107268 8
View Market Depth
Last trade - 10.00am 21/06/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.